Literature DB >> 27232303

pH-responsive zwitterionic polypeptide as a platform for anti-tumor drug delivery.

Na Liu1, Jiaming Han1, Xinchen Zhang1, Yue Yang1, Yuan Liu2, Yanming Wang2, Guolin Wu3.   

Abstract

In this paper, a doxorubicin delivery system is reported based on a pH-responsive zwitterionic polypeptide derivative. To improve the anti-protein-fouling capacity, the poly(amino acid) was modified by grafting short-chain zwitterions via aminolysis reaction of polysuccinimide with l-lysine. As a result, both positively and negatively charged moieties were introduced onto the same side chain in a simultaneous fashion, providing a nano-scale homogenous mixture of balanced charges. The zwitterionic side chains serve as hydrophilic segments in the copolymer and feature excellent resistance to nonspecific protein adsorption. Doxorubicin was chemically grafted onto the poly(amino acid) moiety through acid-labile hydrazone linkages, providing removable hydrophobic segments and driving the polymer self-assembly. Free doxorubicin could be encapsulated into the self-assembled micelles via hydrophobic interactions and molecular π-π stacking. The results obtained show that the drug loaded nanoparticles exhibit excellent stabilities in protein solutions at pH=7.4 and significantly enhanced drug release characteristics under acidic conditions. The cytotoxicity characteristics of the zwitterionic copolymer and drug-loaded nanoparticles at different pH values were investigated in vitro and feature an excellent biocompatibility and anti-cancer activity, respectively.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-protein adsorption; Drug delivery; Polypeptide; Stimuli-responsive; Zwitterionic polymer; pH-sensitive

Mesh:

Substances:

Year:  2016        PMID: 27232303     DOI: 10.1016/j.colsurfb.2016.05.027

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  3 in total

1.  Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells.

Authors:  Xin Guo; Nan Guo; Jianwen Zhao; Yunlang Cai
Journal:  Oncol Rep       Date:  2017-07-18       Impact factor: 3.906

2.  Targeting self-assembled F127-peptide polymer with pH sensitivity for release of anticancer drugs.

Authors:  Wenzhao Han; Fanwei Meng; Hao Gan; Feng Guo; Junfeng Ke; Liping Wang
Journal:  RSC Adv       Date:  2021-01-05       Impact factor: 3.361

3.  A Novel Formulation of Cisplatin with γ-Polyglutamic Acid and Chitosan Reduces Its Adverse Renal Effects: An In Vitro and In Vivo Animal Study.

Authors:  Masao Sasai; Kazuma Sakura; Takayuki Matsuda; Hiroshi Uyama
Journal:  Polymers (Basel)       Date:  2021-05-30       Impact factor: 4.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.